Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC)Counts
Status: Enrolling
Updated:  1/3/2013
Massachusetts General Hospital
mi
from
Boston, MA
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC)Counts
Status: Enrolling
Updated: 1/3/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC)Counts
Status: Enrolling
Updated:  1/3/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
A Pilot Study of PLX3397 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients With Bone Metastasis and High Circulating Tumor Cell (CTC)Counts
Status: Enrolling
Updated: 1/3/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
Status: Enrolling
Updated:  1/4/2013
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer
Status: Enrolling
Updated: 1/4/2013
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated:  1/8/2013
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated: 1/8/2013
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated:  1/8/2013
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated: 1/8/2013
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated:  1/8/2013
Fox Chase Cancer Center
mi
from
Philadephia, PA
A Study of of MORAb-004 in Subjects With Solid Tumors
A Study of the Safety, Tolerability, and Pharmacokinetics of MORAb-004, a Humanized Monoclonal Antibody, in Subjects With Solid Tumors
Status: Enrolling
Updated: 1/8/2013
Fox Chase Cancer Center
mi
from
Philadephia, PA
Click here to add this to my saved trials
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated:  1/8/2013
California Pacific Medical Center
mi
from
San Francisco, CA
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated: 1/8/2013
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated:  1/8/2013
University of Miami
mi
from
Miami, FL
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated: 1/8/2013
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated:  1/8/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated: 1/8/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated:  1/8/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated: 1/8/2013
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated:  1/8/2013
Fox Chase Cancer Center
mi
from
Philadephia, PA
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
A Phase I, Open-Label, Multi-center, Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33 in Combination With Sorafenib (Nexavar®) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status: Enrolling
Updated: 1/8/2013
Fox Chase Cancer Center
mi
from
Philadephia, PA
Click here to add this to my saved trials
Oral Colchicine in Men With Castrate Resistant Prostate Cancer
Phase II Trial of Oral Colchicine in Men With Castrate-Resistant Prostate Cancer Who Have Failed Taxotere-Based Chemotherapy
Status: Enrolling
Updated:  1/8/2013
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Oral Colchicine in Men With Castrate Resistant Prostate Cancer
Phase II Trial of Oral Colchicine in Men With Castrate-Resistant Prostate Cancer Who Have Failed Taxotere-Based Chemotherapy
Status: Enrolling
Updated: 1/8/2013
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Loma Linda University
mi
from
Loma Linda, CA
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Loma Linda University
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Kaiser Permanente
mi
from
Sacremento, CA
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Kaiser Permanente
mi
from
Sacremento, CA
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Prostate Institute of America
mi
from
Ventura, CA
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Prostate Institute of America
mi
from
Ventura, CA
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Univ. of Colorado at Denver and Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Rush University Medical Center
mi
from
Chicago, IL
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Midwest Urology/RMD Clinical Research
mi
from
Melrose Park, IL
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Midwest Urology/RMD Clinical Research
mi
from
Melrose Park, IL
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Methodist Hospital
mi
from
Brooklyn, NY
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Nelson Stone (private practice)
mi
from
New York, NY
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Nelson Stone (private practice)
mi
from
New York, NY
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Riverside Urology, Inc.
mi
from
Columbus, OH
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Riverside Urology, Inc.
mi
from
Columbus, OH
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Rhode Island Hospital/Warren Alpert Medical School of Brown University
mi
from
Providence, RI
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Rhode Island Hospital/Warren Alpert Medical School of Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Medical University of South Carolina
mi
from
Charleston, SC
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
University of Tennessee Cancer Institute - Memphis
mi
from
Memphis, TN
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
University of Tennessee Cancer Institute - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Urology Associates of North Texas
mi
from
Arlington, TX
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Urology Associates of North Texas
mi
from
Arlington, TX
Click here to add this to my saved trials
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated:  1/14/2013
Urology of Virginia, Sentara Medical Group
mi
from
Norfolk, VA
Salvage Cryotherapy in Recurrent Prostate Cancer
A Prospective Multicenter Registry of Salvage Cryotherapy in Recurrent Prostate Cancer Study
Status: Enrolling
Updated: 1/14/2013
Urology of Virginia, Sentara Medical Group
mi
from
Norfolk, VA
Click here to add this to my saved trials
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique
Status: Enrolling
Updated:  1/15/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer
Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique
Status: Enrolling
Updated: 1/15/2013
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
An Open-Label, Multicenter Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  1/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
An Open-Label, Multicenter Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 1/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
An Open-Label, Multicenter Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  1/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
An Open-Label, Multicenter Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 1/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated:  1/17/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated: 1/17/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated:  1/17/2013
Pfizer Investigational Site
mi
from
Houston, TX
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated: 1/17/2013
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated:  1/17/2013
Pfizer Investigational Site
mi
from
Seattle, WA
A Study Of PF-04449913 In Select Hematologic Malignancies
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies
Status: Enrolling
Updated: 1/17/2013
Pfizer Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia: A Randomized Prospective Comparison of Snares and Injectate in the Resection of Large Sessile Colonic Polyps
Status: Enrolling
Updated:  1/17/2013
Mayo Clinic
mi
from
Jacksonville, FL
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia: A Randomized Prospective Comparison of Snares and Injectate in the Resection of Large Sessile Colonic Polyps
Status: Enrolling
Updated: 1/17/2013
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
A Phase I Dose Escalation Study of a 2 Day Oral Lapatinib Chemosensitization Pulse Given Prior To Weekly Intravenous Abraxane™ in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 1/17/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Status: Enrolling
Updated:  1/18/2013
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
Status: Enrolling
Updated: 1/18/2013
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
Status: Enrolling
Updated:  1/18/2013
Rhode Island Hospital
mi
from
Providence, RI
Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
Status: Enrolling
Updated: 1/18/2013
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
Status: Enrolling
Updated:  1/18/2013
Miriam Hospital
mi
from
Providence, RI
Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?
Status: Enrolling
Updated: 1/18/2013
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
University of Washington; UW Medical Center
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
University of Washington; UW Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated:  1/21/2013
Veteran's Affairs Puget Sound HCS
mi
from
Seattle, WA
Improving Clinician Communication Skills (ICCS)
Improving Patient Outcomes in End-of-Life Care Provided by Physicians and Nurses
Status: Enrolling
Updated: 1/21/2013
Veteran's Affairs Puget Sound HCS
mi
from
Seattle, WA
Click here to add this to my saved trials
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
A Phase I Dose Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy With Biomarker Analysis in Patients With HER2-Overexpressing Breast Cancer
Status: Enrolling
Updated:  1/22/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
A Phase I Dose Escalation Study of 5-Day Intermittent Oral Lapatinib Therapy With Biomarker Analysis in Patients With HER2-Overexpressing Breast Cancer
Status: Enrolling
Updated: 1/22/2013
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Status: Enrolling
Updated:  1/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Status: Enrolling
Updated: 1/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated:  1/22/2013
AVEO Clinical Site
mi
from
Scottsdale, AZ
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated: 1/22/2013
AVEO Clinical Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated:  1/22/2013
AVEO Clinical Site
mi
from
Atlanta, GA
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated: 1/22/2013
AVEO Clinical Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated:  1/22/2013
AVEO Clinical Site
mi
from
San Antonio, TX
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors
Status: Enrolling
Updated: 1/22/2013
AVEO Clinical Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Percutaneous Removal and Margin Ablation for Breast Cancer
Percutaneous Removal and Margin Ablation for Breast Cancer
Status: Enrolling
Updated:  1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Percutaneous Removal and Margin Ablation for Breast Cancer
Percutaneous Removal and Margin Ablation for Breast Cancer
Status: Enrolling
Updated: 1/23/2013
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials